KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 3 filers reported holding KARYOPHARM THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $979 | -18.1% | 730,400 | +9.4% | 0.00% | 0.0% |
| Q2 2023 | $1,195 | -58.2% | 667,400 | -9.3% | 0.00% | -50.0% |
| Q1 2023 | $2,862 | +344.4% | 735,700 | +288.6% | 0.00% | +300.0% |
| Q4 2022 | $644 | -100.0% | 189,300 | -38.6% | 0.00% | -50.0% |
| Q3 2022 | $1,683,000 | -17.9% | 308,300 | -32.2% | 0.00% | 0.0% |
| Q2 2022 | $2,051,000 | +29.4% | 454,800 | +111.4% | 0.00% | 0.0% |
| Q1 2022 | $1,585,000 | +187.1% | 215,100 | +150.4% | 0.00% | +100.0% |
| Q4 2021 | $552,000 | -80.9% | 85,900 | -82.7% | 0.00% | -75.0% |
| Q3 2021 | $2,883,000 | +1409.4% | 495,400 | +2581.9% | 0.00% | – |
| Q2 2021 | $191,000 | -94.5% | 18,472 | -89.8% | 0.00% | -100.0% |
| Q2 2020 | $3,443,000 | -66.4% | 181,800 | -66.0% | 0.00% | -70.0% |
| Q1 2020 | $10,258,000 | +233.4% | 534,000 | +232.7% | 0.01% | +400.0% |
| Q4 2019 | $3,077,000 | +599.3% | 160,500 | +118.3% | 0.00% | – |
| Q2 2019 | $440,000 | -91.8% | 73,515 | -92.0% | 0.00% | -100.0% |
| Q1 2019 | $5,366,000 | +34.4% | 918,800 | +115.6% | 0.01% | +25.0% |
| Q4 2018 | $3,994,000 | +231.7% | 426,253 | +502.9% | 0.00% | +300.0% |
| Q3 2018 | $1,204,000 | -48.6% | 70,700 | -48.7% | 0.00% | 0.0% |
| Q2 2018 | $2,343,000 | – | 137,900 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Delphi Management Partners VIII, L.L.C. | 2,263,006 | $13,170,000 | 9.51% |
| Palo Alto Investors LP | 5,383,052 | $31,329,000 | 1.89% |
| Birchview Capital, LP | 246,000 | $1,432,000 | 0.97% |
| Rubric Capital Management LP | 3,375,758 | $19,647,000 | 0.55% |
| Lombard Odier Asset Management (Switzerland) SA | 1,517,804 | $8,834,000 | 0.55% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,401,861 | $8,159,000 | 0.30% |
| AlphaCentric Advisors LLC | 136,000 | $792,000 | 0.20% |
| Bridgefront Capital, LLC | 20,946 | $122,000 | 0.13% |
| Hennion & Walsh Asset Management, Inc. | 407,474 | $2,371,000 | 0.12% |
| Virtus ETF Advisers LLC | 44,364 | $258,000 | 0.11% |